COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2021-11, Vol.28 (4), p.424-425
Hauptverfasser:	Vuk, T., Hećimović, A., Jukić, I., Ravlić, S., Kurtović, T., Rnjak, D., Halassy, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Letter to the Editor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	425
container_issue	4
container_start_page	424
container_title	Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
container_volume	28
creator	Vuk, T. Hećimović, A. Jukić, I. Ravlić, S. Kurtović, T. Rnjak, D. Halassy, B.
description
doi_str_mv	10.1016/j.tracli.2021.06.001
format	Article
fullrecord	<record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8205291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1246782021000835</els_id><sourcerecordid>S1246782021000835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-f9abd8232e1f47ce3265db17c42ee401b915867730f1c7cb8ca65c0bbbe718d23</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0Eorz-gIV_IMHjPJxskFB5VarEBthatjNpXfKSnRZ1xz_wh3wJCUUgNqzuSHPnju4h5BxYCAzSi1XYO2UqG3LGIWRpyBjskSPIkyjIGOf7w8zjNBAZZxNy7P1qMAjIxSGZRDEIHon8iOjpw_PsOoCcmrbZqAq9waanXaV8rWi_RKe6LS1bR21dr5u2wNIa-2VR_aj-4-39Fe1iaZsFXXfUWf_iqWoKqrEZzL0_JQelqjyefesJebq9eZzeB_OHu9n0ah6YOGZ9UOZKFxmPOEIZC4MRT5NCgzAxR4wZ6BySLBUiYiUYYXRmVJoYprVGAVnBoxNyucvt1rrGYuzhVCU7Z2vltrJVVv7dNHYpF-1GDoASnsMQEO8CjGu9d1j-3AKTI3O5kjvmcmQuWSoHpL9_cSi3seikHwkZLKxD08uitf8HfAKMxI7d</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits</title><source>Access via ScienceDirect (Elsevier)</source><creator>Vuk, T. ; Hećimović, A. ; Jukić, I. ; Ravlić, S. ; Kurtović, T. ; Rnjak, D. ; Halassy, B.</creator><creatorcontrib>Vuk, T. ; Hećimović, A. ; Jukić, I. ; Ravlić, S. ; Kurtović, T. ; Rnjak, D. ; Halassy, B.</creatorcontrib><identifier>ISSN: 1246-7820</identifier><identifier>EISSN: 1953-8022</identifier><identifier>DOI: 10.1016/j.tracli.2021.06.001</identifier><identifier>PMID: 34172379</identifier><language>eng</language><publisher>Elsevier Masson SAS</publisher><subject>Letter to the Editor</subject><ispartof>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2021-11, Vol.28 (4), p.424-425</ispartof><rights>2021 Société française de transfusion sanguine (SFTS)</rights><rights>2021 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved. 2021 Société française de transfusion sanguine (SFTS)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-f9abd8232e1f47ce3265db17c42ee401b915867730f1c7cb8ca65c0bbbe718d23</citedby><cites>FETCH-LOGICAL-c440t-f9abd8232e1f47ce3265db17c42ee401b915867730f1c7cb8ca65c0bbbe718d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tracli.2021.06.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Vuk, T.</creatorcontrib><creatorcontrib>Hećimović, A.</creatorcontrib><creatorcontrib>Jukić, I.</creatorcontrib><creatorcontrib>Ravlić, S.</creatorcontrib><creatorcontrib>Kurtović, T.</creatorcontrib><creatorcontrib>Rnjak, D.</creatorcontrib><creatorcontrib>Halassy, B.</creatorcontrib><title>COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits</title><title>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</title><subject>Letter to the Editor</subject><issn>1246-7820</issn><issn>1953-8022</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0Eorz-gIV_IMHjPJxskFB5VarEBthatjNpXfKSnRZ1xz_wh3wJCUUgNqzuSHPnju4h5BxYCAzSi1XYO2UqG3LGIWRpyBjskSPIkyjIGOf7w8zjNBAZZxNy7P1qMAjIxSGZRDEIHon8iOjpw_PsOoCcmrbZqAq9waanXaV8rWi_RKe6LS1bR21dr5u2wNIa-2VR_aj-4-39Fe1iaZsFXXfUWf_iqWoKqrEZzL0_JQelqjyefesJebq9eZzeB_OHu9n0ah6YOGZ9UOZKFxmPOEIZC4MRT5NCgzAxR4wZ6BySLBUiYiUYYXRmVJoYprVGAVnBoxNyucvt1rrGYuzhVCU7Z2vltrJVVv7dNHYpF-1GDoASnsMQEO8CjGu9d1j-3AKTI3O5kjvmcmQuWSoHpL9_cSi3seikHwkZLKxD08uitf8HfAKMxI7d</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Vuk, T.</creator><creator>Hećimović, A.</creator><creator>Jukić, I.</creator><creator>Ravlić, S.</creator><creator>Kurtović, T.</creator><creator>Rnjak, D.</creator><creator>Halassy, B.</creator><general>Elsevier Masson SAS</general><general>Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20211101</creationdate><title>COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits</title><author>Vuk, T. ; Hećimović, A. ; Jukić, I. ; Ravlić, S. ; Kurtović, T. ; Rnjak, D. ; Halassy, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-f9abd8232e1f47ce3265db17c42ee401b915867730f1c7cb8ca65c0bbbe718d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Letter to the Editor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vuk, T.</creatorcontrib><creatorcontrib>Hećimović, A.</creatorcontrib><creatorcontrib>Jukić, I.</creatorcontrib><creatorcontrib>Ravlić, S.</creatorcontrib><creatorcontrib>Kurtović, T.</creatorcontrib><creatorcontrib>Rnjak, D.</creatorcontrib><creatorcontrib>Halassy, B.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vuk, T.</au><au>Hećimović, A.</au><au>Jukić, I.</au><au>Ravlić, S.</au><au>Kurtović, T.</au><au>Rnjak, D.</au><au>Halassy, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits</atitle><jtitle>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</jtitle><date>2021-11-01</date><risdate>2021</risdate><volume>28</volume><issue>4</issue><spage>424</spage><epage>425</epage><pages>424-425</pages><issn>1246-7820</issn><eissn>1953-8022</eissn><pub>Elsevier Masson SAS</pub><pmid>34172379</pmid><doi>10.1016/j.tracli.2021.06.001</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1246-7820
ispartof	Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2021-11, Vol.28 (4), p.424-425
issn	1246-7820 1953-8022
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8205291
source	Access via ScienceDirect (Elsevier)
subjects	Letter to the Editor
title	COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A08%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20convalescent%20plasma%20therapy%20for%20immunodeficient%20patients%E2%80%93weighing%20up%20risks%20and%20benefits&rft.jtitle=Transfusion%20clinique%20et%20biologique%20:%20journal%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20transfusion%20sanguine&rft.au=Vuk,%20T.&rft.date=2021-11-01&rft.volume=28&rft.issue=4&rft.spage=424&rft.epage=425&rft.pages=424-425&rft.issn=1246-7820&rft.eissn=1953-8022&rft_id=info:doi/10.1016/j.tracli.2021.06.001&rft_dat=%3Celsevier_pubme%3ES1246782021000835%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34172379&rft_els_id=S1246782021000835&rfr_iscdi=true